• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型拟胆碱能乙酰胆碱受体混合配体嵌入了奎宁环和 1,4-二氧六环片段。

Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments.

机构信息

Scuola di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Via S. Agostino 1, 62032 Camerino, Italy.

Scuola di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Via S. Agostino 1, 62032 Camerino, Italy; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, MD 21224, USA.

出版信息

Eur J Med Chem. 2017 Sep 8;137:327-337. doi: 10.1016/j.ejmech.2017.06.004. Epub 2017 Jun 3.

DOI:10.1016/j.ejmech.2017.06.004
PMID:28609709
Abstract

To obtain novel muscarinic acetylcholine receptor (mAChR) antagonists, the enantiomers of the hybrid compounds 3-5, in which the quinuclidin-3-yloxy fragment of solifenacin and the 6,6-diphenyl-1,4-dioxane-2-yl moiety of 2 linked by an ester or ether spacer were embedded in the same chemical entity, were prepared and evaluated for their affinity at the five mAChR subtypes (M-M). Stereochemistry and the nature of the linker between the quinuclidine moiety and the 1,4-dioxane nucleus play an important role on the affinities of the compounds. The presence of an ether bridge confers higher affinities for all mAChR subtypes to the ligand. Interestingly, the ether enantiomer (R,S)-5 shows the highest affinity at all mAChR subtypes with pK values similar to that of solifenacin at M and higher at the other subtypes. Unlike solifenacin, it shows a preference for M mAChR subtype with respect to the other subtypes. This compound, lacking a permanent positive charge on the nitrogen atom, can be a useful tool for the pharmacological study of mAChRs in the central nervous system.

摘要

为了获得新型毒蕈碱乙酰胆碱受体(mAChR)拮抗剂,我们合成了手性化合物 3-5 的对映异构体,其中索利那新的奎宁环-3-氧基片段和 2 的 6,6-二苯基-1,4-二氧六环-2-基部分通过酯或醚间隔基连接在同一化学实体中。对这些化合物在五种 mAChR 亚型(M-M)上的亲和力进行了评价。立体化学和连接奎宁环部分与 1,4-二氧六环核的键的性质对化合物的亲和力起着重要作用。醚桥的存在赋予配体对所有 mAChR 亚型更高的亲和力。有趣的是,醚对映异构体(R,S)-5 在所有 mAChR 亚型上都表现出最高的亲和力,pK 值与索利那新在 M 型上的相似,在其他亚型上更高。与索利那新不同,它对 M mAChR 亚型表现出偏好,而对其他亚型则没有。该化合物氮原子上没有永久正电荷,可作为研究中枢神经系统 mAChRs 的药理学工具。

相似文献

1
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments.新型拟胆碱能乙酰胆碱受体混合配体嵌入了奎宁环和 1,4-二氧六环片段。
Eur J Med Chem. 2017 Sep 8;137:327-337. doi: 10.1016/j.ejmech.2017.06.004. Epub 2017 Jun 3.
2
New potent muscarinic receptor ligands bearing the 1,4-dioxane nucleus: Investigation on the nature of the substituent in position 2.具有 1,4-二恶烷核的新型强效毒蕈碱受体配体:研究 2 位取代基的性质。
Arch Pharm (Weinheim). 2024 Oct;357(10):e2400337. doi: 10.1002/ardp.202400337. Epub 2024 Jul 25.
3
Novel Potent Muscarinic Receptor Antagonists: Investigation on the Nature of Lipophilic Substituents in the 5- and/or 6-Positions of the 1,4-Dioxane Nucleus.新型强效毒蕈碱受体拮抗剂:1,4-二恶烷核 5-和/或 6-位脂溶性取代基性质的研究。
J Med Chem. 2020 Jun 11;63(11):5763-5782. doi: 10.1021/acs.jmedchem.9b02100. Epub 2020 May 19.
4
Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.新型奎宁环衍生物系列中具有强效抗毒蕈碱活性。
Bioorg Med Chem Lett. 2006 Jan 15;16(2):373-7. doi: 10.1016/j.bmcl.2005.09.079. Epub 2005 Nov 3.
5
Muscarinic agonist, (±)-quinuclidin-3-yl-(4-fluorophenethyl)(phenyl)carbamate: High affinity, but low subtype selectivity for human M - M muscarinic acetylcholine receptors.毒蕈碱激动剂,(±)-4-氟苯乙基-1-(4-氟苯基)-1,2,3,6-四氢吡啶基-3-甲氨基甲酸酯:对人 M 1-M 5 毒蕈碱型乙酰胆碱受体具有高亲和力,但低亚型选择性。
Bioorg Med Chem Lett. 2019 Feb 1;29(3):471-476. doi: 10.1016/j.bmcl.2018.12.022. Epub 2018 Dec 11.
6
Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.炔基奎宁环衍生物作为治疗慢性阻塞性肺疾病的强效和选择性毒蕈碱拮抗剂。
Bioorg Med Chem Lett. 2008 Apr 15;18(8):2675-8. doi: 10.1016/j.bmcl.2008.03.024. Epub 2008 Mar 18.
7
Muscarinic acetylcholine receptor (mAChR) inhibitor from snake venom: interaction with subtypes of human mAChR.蛇毒中的毒蕈碱型乙酰胆碱受体(mAChR)抑制剂:与人mAChR亚型的相互作用
Arch Biochem Biophys. 1999 Sep 1;369(1):114-8. doi: 10.1006/abbi.1999.1321.
8
Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.奎宁环-3-基 1,2,3,4-四氢异喹啉-2-羧酸酯衍生物作为新型毒蕈碱受体拮抗剂的合成及抗毒蕈碱特性
J Med Chem. 2005 Oct 20;48(21):6597-606. doi: 10.1021/jm050099q.
9
Synthesis and SAR of selective muscarinic acetylcholine receptor subtype 1 (M1 mAChR) antagonists.选择性毒蕈碱型乙酰胆碱受体亚型1(M1 mAChR)拮抗剂的合成与构效关系
Bioorg Med Chem Lett. 2008 Feb 1;18(3):885-90. doi: 10.1016/j.bmcl.2007.12.051. Epub 2008 Jan 4.
10
3-Heteroarylquinuclidin-2-ene derivatives as muscarinic antagonists: synthesis, structure-activity relationships and molecular modelling.作为毒蕈碱拮抗剂的3-杂芳基奎宁环-2-烯衍生物:合成、构效关系及分子模拟
Prog Brain Res. 1996;109:141-5. doi: 10.1016/s0079-6123(08)62095-6.

引用本文的文献

1
Scaffold Hybridization Strategy Leads to the Discovery of Dopamine D Receptor-Selective or Multitarget Bitopic Ligands Potentially Useful for Central Nervous System Disorders.支架杂交策略导致发现多巴胺 D 受体选择性或多靶点双位点配体,可能对中枢神经系统疾病有用。
ACS Chem Neurosci. 2021 Oct 6;12(19):3638-3649. doi: 10.1021/acschemneuro.1c00368. Epub 2021 Sep 16.
2
Novel Potent Muscarinic Receptor Antagonists: Investigation on the Nature of Lipophilic Substituents in the 5- and/or 6-Positions of the 1,4-Dioxane Nucleus.新型强效毒蕈碱受体拮抗剂:1,4-二恶烷核 5-和/或 6-位脂溶性取代基性质的研究。
J Med Chem. 2020 Jun 11;63(11):5763-5782. doi: 10.1021/acs.jmedchem.9b02100. Epub 2020 May 19.
3
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells.
N-甲基-D-天冬氨酸受体在手性1,4-二氧六环配体对MCF-7和SKBR3乳腺癌细胞的抗肿瘤活性中的作用
ACS Med Chem Lett. 2019 Jan 28;10(4):511-516. doi: 10.1021/acsmedchemlett.8b00536. eCollection 2019 Apr 11.
4
Dehydrogenative reagent-free annulation of alkenes with diols for the synthesis of saturated O-heterocycles.无脱氢试剂条件下烯烃与二元醇的环化反应合成饱和 O-杂环化合物。
Nat Commun. 2018 Sep 3;9(1):3551. doi: 10.1038/s41467-018-06020-8.